Jianwei Zhu

Jianwei Zhu is an accomplished business development leader with extensive experience in mergers and acquisitions spanning various sectors, particularly healthcare. Currently serving as Senior Director of Business Development, M&A, and Strategy at Melinta Therapeutics since May 2025, Jianwei previously held senior leadership roles at Siemens Healthineers, where over 25 successful transactions were executed, totaling more than $5B in deal value. Jianwei's background includes financial advisory roles at Deutsche Bank and corporate development positions at Fresenius Medical Care, emphasizing strategic M&A and financial performance. Educational qualifications include an MBA from NYU Stern School of Business and a BSB in Accounting and Finance from the UMN Carlson School of Management.